Trial intelligence / Profile preview

Surgicel as Analgesic Reservoir for Post-Laparoscopic Cholecystectomy Pain

NCT03730714Phase 3Completed

Sponsor
Assiut University
Start
Nov 2018
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Visual Analogue Scale at 24 hours. Started Nov 2018; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03730714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03730714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call